We are live on ! Find out more
Vectors Research Management

Vectors Research Management Portfolio holdings

AUM $362M Turnover 8.5%
1-Year Est. Return 21.88%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+21.88%
3 Year Est. Return
+71.37%
5 Year Est. Return
+73.19%
10 Year Est. Return
–
AUM
$362M
AUM Growth
-$21.4M
Cap. Flow
-$12.9M
Cap. Flow %
-3.56%
Top 10 Hldgs %
35.28%
Holding
153
New
5
Increased
48
Reduced
62
Closed
8
Avg Time Held
4.3 years
Top 10 Avg Time Held
2.7 years
Top 20 Avg Time Held
2.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.35%
2 Technology 21.7%
3 Industrials 9.31%
4 Energy 6.21%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MDT icon
151
Medtronic
MDT
$128B
– –
-29,312
Closed -$2.29M –
SNA icon
152
Snap-on
SNA
$18B
– –
-535
Closed -$215K –
OKLO icon
153
Oklo
OKLO
$3.88B
– –
-4,060
Closed -$212K –

Similar funds

Vectors Research Management's Q3 2026 Portfolio in Review

As of Q3 2026, Vectors Research Management held 153 positions worth $362M, down 5.6% from $383M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Vectors Research Management withdrew a net $12.9M in Q3 2026, closing 8 positions and reducing 62 holdings. Its most notable exit was Medtronic, an estimated $2.29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 40% a quarter earlier, followed by Technology and Industrials.

Against the trend, Vectors Research Management opened a new position in iShares 1-5 Year Investment Grade Corporate Bond ETF worth $526K.

  • Vectors Research Management's largest Q3 2026 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 10,266 shares worth $526K.
  • Vectors Research Management added most to iShares 0-3 Month Treasury Bond ETF in Q3 2026, an estimated $1.36M increase.
  • Vectors Research Management's biggest Q3 2026 reduction was Vanguard FTSE Europe ETF, cutting an estimated $4.8M.
  • Vectors Research Management fully exited Medtronic in Q3 2026, selling an estimated $2.29M.
  • Vectors Research Management's ten largest holdings make up 35% of its $362M portfolio in Q3 2026.
  • Vectors Research Management opened 5 new positions and closed 8 in Q3 2026.
  • Vectors Research Management's portfolio value fell 5.6% quarter-over-quarter to $362M.

Based on Vectors Research Management's 13F filing for Q3 2026, filed 9 Nov 2026.